These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 17099598)

  • 21. Suicidal risk and executive functions in major depressive disorder: a study protocol.
    Roca M; Del Amo AR; Riera-Serra P; Pérez-Ara MA; Castro A; Roman Juan J; García-Toro M; García-Pazo P; Gili M
    BMC Psychiatry; 2019 Aug; 19(1):253. PubMed ID: 31420027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronavigation-Guided rTMS for the Treatment of Depressive Patients With Suicidal Ideation: A Double-Blind, Randomized, Sham-Controlled Trial.
    Pan F; Shen Z; Jiao J; Chen J; Li S; Lu J; Duan J; Wei N; Shang D; Hu S; Xu Y; Huang M
    Clin Pharmacol Ther; 2020 Oct; 108(4):826-832. PubMed ID: 32319673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with major depressive disorder.
    Baek JH; Heo JY; Fava M; Mischoulon D; Nierenberg A; Hong JP; Roh S; Jeon HJ
    J Affect Disord; 2015 Nov; 187():183-7. PubMed ID: 26342171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME
    J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
    Ballard ED; Luckenbaugh DA; Richards EM; Walls TL; Brutsché NE; Ameli R; Niciu MJ; Vande Voort JL; Zarate CA
    J Psychiatr Res; 2015 Sep; 68():68-73. PubMed ID: 26228403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Brief Therapy for Patients Who Attempt Suicide: A 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP).
    Gysin-Maillart A; Schwab S; Soravia L; Megert M; Michel K
    PLoS Med; 2016 Mar; 13(3):e1001968. PubMed ID: 26930055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of continued suicidal behavior in adolescents following a suicide attempt.
    Spirito A; Valeri S; Boergers J; Donaldson D
    J Clin Child Adolesc Psychol; 2003 Jun; 32(2):284-9. PubMed ID: 12679287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suicide assessment: clinical interview vs. self-report.
    Kaplan ML; Asnis GM; Sanderson WC; Keswani L; De Lecuona JM; Joseph S
    J Clin Psychol; 1994 Mar; 50(2):294-8. PubMed ID: 8014256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurobiological and psychological correlates of suicidal attempts and thoughts of death in patients with major depression.
    Fountoulakis KN; Iacovides A; Fotiou F; Nimatoudis J; Bascialla F; Ioannidou C; Kaprinis G; Bech P
    Neuropsychobiology; 2004; 49(1):42-52. PubMed ID: 14730200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Modified Scale for Suicidal Ideation: factors of suicidality and their relation to clinical and diagnostic variables.
    Joiner TE; Rudd MD; Rajab MH
    J Abnorm Psychol; 1997 May; 106(2):260-5. PubMed ID: 9131846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor analyses of the Suicidal Intent Scale (SIS) and the Risk-Rescue Rating Scale (RRRS): toward the identification of homogeneous subgroups of suicidal behaviors.
    Misson H; Mathieu F; Jollant F; Yon L; Guillaume S; Parmentier C; Raust A; Jaussent I; Slama F; Leboyer M; Bellivier F; Courtet P
    J Affect Disord; 2010 Feb; 121(1-2):80-7. PubMed ID: 19524302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy assessment of weak variable magnetic fields with low value of induction in patients with drug-resistant depression.
    Sobiś J; Jarzab M; Hese RT; Sieroń A; Zyss T; Gorczyca P; Gierlotka Z; Pudlo R; Matysiakiewicz J
    J Affect Disord; 2010 Jun; 123(1-3):321-6. PubMed ID: 19896204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method of assessment determines prevalence of suicidal ideation among patients with depression.
    Vuorilehto M; Valtonen HM; Melartin T; Sokero P; Suominen K; Isometsä ET
    Eur Psychiatry; 2014 Aug; 29(6):338-44. PubMed ID: 24176645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective psychological well-being (WHO-5) in assessment of the severity of suicide attempt.
    Sisask M; Värnik A; Kõlves K; Konstabel K; Wasserman D
    Nord J Psychiatry; 2008; 62(6):431-5. PubMed ID: 18846444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
    Meyer RE; Salzman C; Youngstrom EA; Clayton PJ; Goodwin FK; Mann JJ; Alphs LD; Broich K; Goodman WK; Greden JF; Meltzer HY; Normand SL; Posner K; Shaffer D; Oquendo MA; Stanley B; Trivedi MH; Turecki G; Beasley CM; Beautrais AL; Bridge JA; Brown GK; Revicki DA; Ryan ND; Sheehan DV
    J Clin Psychiatry; 2010 Aug; 71(8):e1-e21. PubMed ID: 20797373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.
    Zisook S; Kasckow JW; Lanouette NM; Golshan S; Fellows I; Vahia I; Mohamed S; Rao S
    J Clin Psychiatry; 2010 Jul; 71(7):915-22. PubMed ID: 20361918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.